GSK plc
Search results
We are Haleon. We are a world-leading consumer health company with a clear purpose to deliver better everyday health with humanity. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally.
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.
We are a world-leading consumer health company. Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally.
Feb 22, 2022 · Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol and Centrum. Business is on track to demerge and list as a new company in mid-2022.
Information on Haleon brands and brand categories, Oral Health, Vitamins, Minerals and Supplements (VMS), Pain, Respiratory, Digestive and Other.
Feb 28, 2022 · Haleon has been created from a series of progressive strategic moves to develop the GSK Consumer Healthcare business. The business has been transformed through the successful integrations of the Novartis consumer health portfolio in 2015 and the Pfizer portfolio in 2019.
Jun 1, 2022 · On Monday 18 July 2022, GSK plc (“GSK” or the “Company”) separated its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. The separation was effected by way of a demerger (the “Demerger”) of approximately 80% of GSK’s 68% holding in the Consumer Healthcare ...
Jul 18, 2022 · Haleon, a joint venture with Pfizer that includes assets bought from Novartis, is the only listed pure-play consumer health group available to investors.
Jun 1, 2022 · However, in keeping with Pfizer’s transformation into a more focused, global leader in science-based innovative medicines and vaccines, the company intends to exit its 32% ownership interest in Haleon in a disciplined manner, with the objective of maximizing value for Pfizer shareholders.
Find the latest Haleon plc (HLN) stock quote, history, news and other vital information to help you with your stock trading and investing.
